Home » Newsletters » BioWorld Science

BioWorld Science

March 2, 2022

View Archived Issues

New HDAC6 inhibitors identified at Italfarmaco

Antengene Discover, Shanghai Antengene present new serine/threonine-protein kinase ATR inhibitors

Spexis, University of Zurich describe new antimicrobial peptidomimetics

Complement factor B inhibitors discovered at Shanghai Meiyue Biotech Development

Bayer, Deutsches Krebsforschungszentrum patent aryl hydrocarbon receptor antagonists

SIGLEC-6 targeting inhibits human mast cell degranulation and anaphylaxis

HLA-DPB1*05:01 allele predicts nonresponse to SLIT in allergic rhinitis

JAK1 activation of sensory neurons suppresses lung inflammation

Quanterix collaborates with Lilly on diagnosis and treatment of Alzheimer's disease

LIGHT mediates esophageal remodeling in murine model of eosinophilic esophagitis

HuR ablation ameliorates allergen-induced asthmatic symptoms

Neuropathy may unify disparate long COVID symptoms

Targeting PD-1/PD-L1 pathway prevents allergic immune response

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...